01 1Synthon Pharmaceuticals
01 1ENZALUTAMIDE
01 1Netherlands
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-12-07
Pay. Date : 2021-10-27
DMF Number : 36447
Submission : 2021-10-29
Status : Active
Type : II
20
Synthon Bv, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ENZALUTAMIDE, with a corresponding US DMF Number 36447.
Remarkably, this DMF maintains an Active status since its submission on October 29, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 07, 2021, and payment made on October 27, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
